or Try an Advanced Search...

    Technical Analysis for SLDB - Solid Biosciences Inc.

    Grade Last Price % Change Price Change
    F 5.31 -4.50% -0.25
    SLDB closed down 4.5 percent on Thursday, November 14, 2024, on 1.42 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical SLDB trend table...
    Date Alert Name Type % Chg
    Bollinger Band Squeeze Range Contraction 0.00%
    NR7 Range Contraction 0.00%
    Stochastic Reached Oversold Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    20 DMA Resistance Bearish -4.50%
    Bollinger Band Squeeze Range Contraction -4.50%
    Inside Day Range Contraction -4.50%
    Fell Below 20 DMA Bearish -3.63%
    Bollinger Band Squeeze Range Contraction -3.63%
    BB Squeeze Started Range Contraction -3.63%
    Older End-of-Day Signals for SLDB ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 13 hours ago
    Up 1% about 14 hours ago
    Down 3% about 17 hours ago
    Fell Below Lower Bollinger Band about 17 hours ago
    Fell Below Previous Day's Low about 17 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    SLDB Chart by TradingView
    Basic chart:

    Profile

    Solid Biosciences Inc is a life science company engaged in developing therapies for Duchenne muscular dystrophy. Its product candidate, SGT-001, is a gene transfer under development to restore functional dystrophin protein expression in patients' muscles.
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Dystrophy Muscular Dystrophy Duchenne Muscular Dystrophy Duchenne Cytoskeleton Dystrophin

    Is SLDB a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 14 Solid Biosciences to Present at the Jefferies London Healthcare Conference
    Nov 9 We're Keeping An Eye On Solid Biosciences' (NASDAQ:SLDB) Cash Burn Rate
    Nov 7 Solid Biosciences GAAP EPS of -$0.79 beats by $0.02
    Nov 6 Solid Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Updates
    Oct 31 Solid Biosciences to Participate at the Truist Securities BioPharma Symposium
    Oct 2 Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    Sep 23 Solid Biosciences to Participate at Chardan’s 8th Annual Genetic Medicines Conference
    Sep 12 Solid Biosciences to Participate at the 2024 Cantor Global Healthcare Conference
    Sep 4 Solid Biosciences to Participate at Upcoming Investor Conferences
    Aug 13 Solid Biosciences reports Q2 results
    See more SLDB news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 15.05
    52 Week Low 2.21
    Average Volume 280,225
    200-Day Moving Average 8.50
    50-Day Moving Average 6.60
    20-Day Moving Average 5.77
    10-Day Moving Average 5.75
    Average True Range 0.44
    RSI (14) 37.89
    ADX 16.18
    +DI 17.04
    -DI 25.64
    Chandelier Exit (Long, 3 ATRs) 5.73
    Chandelier Exit (Short, 3 ATRs) 6.59
    Upper Bollinger Bands 6.29
    Lower Bollinger Band 5.24
    Percent B (%b) 0.07
    BandWidth 18.26
    MACD Line -0.29
    MACD Signal Line -0.31
    MACD Histogram 0.0222
    Fundamentals Value
    Market Cap 198.8 Million
    Num Shares 37.4 Million
    EPS 73.71
    Price-to-Earnings (P/E) Ratio 0.07
    Price-to-Sales 11.89
    Price-to-Book 2.02
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 5.82
    Resistance 3 (R3) 5.87 5.74 5.74
    Resistance 2 (R2) 5.74 5.61 5.72 5.71
    Resistance 1 (R1) 5.53 5.53 5.47 5.48 5.68
    Pivot Point 5.40 5.40 5.37 5.38 5.40
    Support 1 (S1) 5.19 5.27 5.12 5.14 4.94
    Support 2 (S2) 5.06 5.19 5.04 4.91
    Support 3 (S3) 4.85 5.06 4.88
    Support 4 (S4) 4.80